Also trades as: ZYDUSWELL.BO (BSE) · $vol 0M
ZYDUSWELL.NS NSE
Zydus Wellness Limited
1W: -5.2%
1M: -6.7%
3M: -17.4%
YTD: +18.4%
1Y: +26.6%
3Y: +73.3%
5Y: +15.8%
₹485.50 ($5.04)
-7.75 (-1.57%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$39.6B
+46.2% ▲
5Y CAGR: +16.2%
Gross Profit
$19.3B
+79.6% ▲
5Y CAGR: +13.9%
Operating Income
$3.6B
+1.2% ▲
5Y CAGR: +2.2%
Net Income
$2.0B
-43.2% ▼
5Y CAGR: +10.7%
EPS (Diluted)
$6.20
-43.1% ▼
5Y CAGR: +9.7%
EBITDA
$4.8B
+19.1% ▲
5Y CAGR: +16.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $20.1B | $22.5B | $23.3B | $27.1B | $39.6B |
| YoY Growth | +7.6% | +12.2% | +3.2% | +16.4% | +46.2% |
| Cost of Revenue | $12.7B | $11.6B | $11.5B | $12.8B | $20.3B |
| Gross Profit | $7.4B | $11.0B | $8.9B | $10.8B | $19.3B |
| Gross Margin | 36.9% | 48.6% | 38.1% | 39.8% | 48.8% |
| R&D Expenses | $95M | $85M | $48M | $130M | $0 |
| SG&A Expenses | $3.9B | $4.4B | $2.6B | $5.9B | $6.5B |
| Operating Expenses | $4.2B | $5.3B | $5.7B | $3.3B | $15.8B |
| Operating Income | $3.2B | $3.1B | $2.8B | $3.5B | $3.6B |
| Operating Margin | 16.0% | 13.9% | 12.2% | 13.0% | 9.0% |
| Interest Expense | $255M | $161M | $240M | $120M | $981M |
| Income Before Tax | $3.1B | $2.9B | $2.6B | $3.6B | $2.3B |
| Tax Expense | -$28M | -$195M | -$68M | $119M | $333M |
| Net Income | $3.1B | $3.1B | $2.7B | $3.5B | $2.0B |
| Net Margin | 15.4% | 13.8% | 11.5% | 12.8% | 5.0% |
| EPS (Diluted) | $9.71 | $9.76 | $8.39 | $10.90 | $6.20 |
| EBITDA | $3.6B | $3.3B | $3.1B | $4.0B | $4.8B |
| Shares Outstanding | 64M | 64M | 64M | 64M | 318M |